These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 2138254
1. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study. Deray G, Maistre G, Cacoub P, Barthelemy C, Eurin J, Carayon A, Masson F, Martinez F, Baumelou A, Legrand JC. Nephron; 1990; 54(2):148-53. PubMed ID: 2138254 [Abstract] [Full Text] [Related]
2. Plasma atrial natriuretic peptide in patients with chronic renal failure. Chen JH, Tsai JH, Lai YH, Hwang SJ. J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224 [Abstract] [Full Text] [Related]
3. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C, Metzele A, Steffgen J, Grünert A. Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [Abstract] [Full Text] [Related]
4. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754 [Abstract] [Full Text] [Related]
5. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B. Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271 [Abstract] [Full Text] [Related]
6. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 Feb; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
7. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grünert A. Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153 [Abstract] [Full Text] [Related]
8. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD. Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Grabensee B. Adv Perit Dial; 1990 Jun; 6():211-9. PubMed ID: 1982811 [Abstract] [Full Text] [Related]
9. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Saxenhofer H, Gnädinger MP, Weidmann P, Shaw S, Schohn D, Hess C, Uehlinger DE, Jahn H. Kidney Int; 1987 Oct; 32(4):554-61. PubMed ID: 2963167 [Abstract] [Full Text] [Related]
10. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis. Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J. Adv Perit Dial; 1989 Oct; 5():20-3. PubMed ID: 2577411 [Abstract] [Full Text] [Related]
11. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. Plum J, Grabensee B. J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125 [Abstract] [Full Text] [Related]
12. Plasma concentrations of immunoreactive-atrial natriuretic polypeptide in patients on hemodialysis. Kojima S, Inoue I, Hirata Y, Kimura G, Saito F, Kawano Y, Satani M, Ito K, Omae T. Nephron; 1987 Mar; 46(1):45-8. PubMed ID: 2955237 [Abstract] [Full Text] [Related]
13. [Levels of endothelin and atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure treated by hemodialysis]. Kowalska K, Grzeszczak W, Kowalski D. Pol Arch Med Wewn; 1993 Nov; 90(5):334-41. PubMed ID: 8146034 [Abstract] [Full Text] [Related]
14. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Takahashi M, Nagake Y, Ichikawa H, Kawabata K, Nakazono H, Hirata K, Ogura T, Makino H. Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825 [Abstract] [Full Text] [Related]
15. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Am J Kidney Dis; 1994 Sep; 24(3):461-72. PubMed ID: 8079971 [Abstract] [Full Text] [Related]
16. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. de Châtel R, Makó J, Tóth M, Barna I, Lang RE. Int Urol Nephrol; 1991 Sep; 23(2):177-83. PubMed ID: 1830872 [Abstract] [Full Text] [Related]
17. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure. Buckley MG, Sagnella GA, Markandu ND, Singer DR, MacGregor GA. Clin Sci (Lond); 1989 Nov; 77(5):573-9. PubMed ID: 2531055 [Abstract] [Full Text] [Related]
18. [Secretion of atrial natriuretic peptide and vasopressin during hemodialysis in patients with chronic renal failure]. Grzeszczak W, Sornek E, Zukowska-Szczechowska E, Mizera W, Klajnowicz J. Pol Arch Med Wewn; 1995 Sep; 94(3):195-207. PubMed ID: 8596756 [Abstract] [Full Text] [Related]
19. Relationship between Doppler transmitral flow velocity pattern and plasma atrial and brain natriuretic peptide concentrations in anuric patients on maintenance hemodialysis. Ito S, Murai S, Takada N, Ozasa A, Hanada M, Sugiyama M, Suzuki K, Nagae Y, Inagaki T, Takeda Y, Fukutomi T, Joh T. Int Heart J; 2006 May; 47(3):401-8. PubMed ID: 16823246 [Abstract] [Full Text] [Related]
20. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure. Takagi T, Nishikawa M, Inada M. Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]